Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3)

Eleonore Beurel, Suzanne M. Michalek, Richard S Jope

Research output: Contribution to journalArticle

239 Citations (Scopus)

Abstract

In just a few years, the view of glycogen synthase kinase-3 (GSK3) has been transformed from an obscure enzyme seldom encountered in the immune literature to one implicated in an improbably large number of roles. GSK3 is a crucial regulator of the balance between pro- and anti-inflammatory cytokine production in both the periphery and the central nervous system, so that GSK3 inhibitors such as lithium can diminish inflammation. GSK3 influences T-cell proliferation, differentiation and survival. Many effects stem from GSK3 regulation of critical transcription factors, such as NF-κB, NFAT and STATs. These discoveries led to the rapid application of GSK3 inhibitors to animal models of sepsis, arthritis, colitis, multiple sclerosis and others, demonstrating their potential for therapeutic intervention.

Original languageEnglish
Pages (from-to)24-31
Number of pages8
JournalTrends in Immunology
Volume31
Issue number1
DOIs
StatePublished - Jan 1 2010
Externally publishedYes

Fingerprint

Glycogen Synthase Kinase 3
Adaptive Immunity
Innate Immunity
Colitis
Lithium
Multiple Sclerosis
Arthritis
Cell Differentiation
Cell Survival
Sepsis
Anti-Inflammatory Agents
Transcription Factors
Central Nervous System
Animal Models
Cell Proliferation
Cytokines
Inflammation
T-Lymphocytes
Enzymes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). / Beurel, Eleonore; Michalek, Suzanne M.; Jope, Richard S.

In: Trends in Immunology, Vol. 31, No. 1, 01.01.2010, p. 24-31.

Research output: Contribution to journalArticle

@article{d2058caec86347a095fc6146147f46e8,
title = "Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3)",
abstract = "In just a few years, the view of glycogen synthase kinase-3 (GSK3) has been transformed from an obscure enzyme seldom encountered in the immune literature to one implicated in an improbably large number of roles. GSK3 is a crucial regulator of the balance between pro- and anti-inflammatory cytokine production in both the periphery and the central nervous system, so that GSK3 inhibitors such as lithium can diminish inflammation. GSK3 influences T-cell proliferation, differentiation and survival. Many effects stem from GSK3 regulation of critical transcription factors, such as NF-κB, NFAT and STATs. These discoveries led to the rapid application of GSK3 inhibitors to animal models of sepsis, arthritis, colitis, multiple sclerosis and others, demonstrating their potential for therapeutic intervention.",
author = "Eleonore Beurel and Michalek, {Suzanne M.} and Jope, {Richard S}",
year = "2010",
month = "1",
day = "1",
doi = "10.1016/j.it.2009.09.007",
language = "English",
volume = "31",
pages = "24--31",
journal = "Trends in Immunology",
issn = "1471-4906",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3)

AU - Beurel, Eleonore

AU - Michalek, Suzanne M.

AU - Jope, Richard S

PY - 2010/1/1

Y1 - 2010/1/1

N2 - In just a few years, the view of glycogen synthase kinase-3 (GSK3) has been transformed from an obscure enzyme seldom encountered in the immune literature to one implicated in an improbably large number of roles. GSK3 is a crucial regulator of the balance between pro- and anti-inflammatory cytokine production in both the periphery and the central nervous system, so that GSK3 inhibitors such as lithium can diminish inflammation. GSK3 influences T-cell proliferation, differentiation and survival. Many effects stem from GSK3 regulation of critical transcription factors, such as NF-κB, NFAT and STATs. These discoveries led to the rapid application of GSK3 inhibitors to animal models of sepsis, arthritis, colitis, multiple sclerosis and others, demonstrating their potential for therapeutic intervention.

AB - In just a few years, the view of glycogen synthase kinase-3 (GSK3) has been transformed from an obscure enzyme seldom encountered in the immune literature to one implicated in an improbably large number of roles. GSK3 is a crucial regulator of the balance between pro- and anti-inflammatory cytokine production in both the periphery and the central nervous system, so that GSK3 inhibitors such as lithium can diminish inflammation. GSK3 influences T-cell proliferation, differentiation and survival. Many effects stem from GSK3 regulation of critical transcription factors, such as NF-κB, NFAT and STATs. These discoveries led to the rapid application of GSK3 inhibitors to animal models of sepsis, arthritis, colitis, multiple sclerosis and others, demonstrating their potential for therapeutic intervention.

UR - http://www.scopus.com/inward/record.url?scp=73149097234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73149097234&partnerID=8YFLogxK

U2 - 10.1016/j.it.2009.09.007

DO - 10.1016/j.it.2009.09.007

M3 - Article

C2 - 19836308

AN - SCOPUS:73149097234

VL - 31

SP - 24

EP - 31

JO - Trends in Immunology

JF - Trends in Immunology

SN - 1471-4906

IS - 1

ER -